marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 12-05-2024
KalVista Pharmaceuticals Financial Ratios 2011-2024 | KALV
Annual Financial Ratios KalVista Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.4 | -6.9 | -16.7 | -5.5 | -1.8 | -0.8 | - | - | - | - | - |
P/S |
- | 15.7 | 21.5 | 10.3 | 22.0 | 4.1 | - | - | - | - | - |
EPS |
-2.4 | -1.6 | -1.4 | -1.5 | -4.5 | -26.2 | -1.3 | -21.8 | -13.4 | - | - |
EV (Enterprise Value) |
198 M | 193 M | 337 M | 69.8 M | 5.15 M | -9.74 M | -46.2 M | 46.9 M | 43.8 M | 36.8 M | - |
EBITDA per Share |
-3.01 | -2.25 | -1.95 | -1.79 | -4.8 | -25.6 | - | - | - | - | - |
EV/EBITDA |
-3.4 | -4.6 | -10.7 | -1.9 | -0.1 | 0.9 | - | - | - | - | - |
PEG |
0.31 | -0.36 | 1.7 | 0.08 | 0.02 | -0.02 | - | - | - | - | - |
P/B |
0.9 | 2.4 | 3.6 | 3.2 | 1.1 | 0.4 | - | - | - | - | - |
P/CF |
-8.2 | -4.4 | -9.3 | 9.5 | -1.4 | -0.7 | - | - | - | - | - |
ROE % |
-17.98 | -34.76 | -21.52 | -57.99 | -59.38 | -53.20 | - | - | - | - | - |
ROA % |
-17.00 | -31.47 | -17.62 | -25.75 | -54.17 | -46.22 | - | - | - | - | - |
ROCE % |
-22.09 | -47.79 | -29.80 | -49.00 | -71.31 | -70.62 | -87.62 | - | - | - | - |
Current Ratio |
- | 11.5 | 6.4 | 2.6 | 11.3 | 7.6 | 2.1 | - | - | - | - |
DSO |
- | 475.4 | 256.1 | 297.2 | 618.1 | 383.1 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios KalVista Pharmaceuticals
| 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.91 | - | -0.84 | -0.8 | -0.74 | - | -0.75 | -0.9 | -0.94 | - | -0.56 | -0.8 | -1.46 | - | -0.52 | -0.58 | -0.58 | -0.61 | -0.23 | -0.33 | -0.33 | -0.42 | -0.49 | -0.22 | -0.22 | -0.47 | -1.03 | -0.5 | -0.5 | -0.51 | - | -0.09 | -0.28 | -0.25 | -0.21 | -0.19 | -0.4 | -7.38 | -6.82 | -5.89 | -4.26 | -4.39 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | -0.84 | - | -0.95 | -1.05 | -1.07 | - | -0.7 | -0.95 | -1.75 | - | -0.71 | -0.69 | -0.7 | -0.8 | -0.39 | -0.51 | -0.51 | -0.54 | -0.4 | -0.32 | -0.31 | -0.64 | -1.06 | -0.59 | -0.59 | -0.56 | -6.05 | -0.09 | -0.26 | -0.25 | - | -0.18 | -0.25 | -6.94 | - | -5.21 | -3.91 | -4.02 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-121.24 | -75.10 | -86.65 | -65.43 | -56.75 | -41.03 | -58.18 | -63.79 | -56.95 | -40.42 | -47.02 | -40.21 | -47.62 | -49.03 | -56.97 | -50.42 | -40.41 | -30.40 | -23.08 | -37.60 | -34.65 | -31.70 | -43.66 | -47.28 | -60.23 | -73.18 | -72.45 | -57.55 | -48.53 | -52.89 | -42.76 | -54.24 | -56.35 | -54.23 | -49.40 | -27.26 | -9.08 | 15.16 | 30.24 | 19.57 | 10.52 | 4.56 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-97.15 | -61.19 | -70.66 | -54.65 | -48.39 | -35.77 | -50.95 | -56.66 | -51.05 | -37.04 | -42.96 | -36.81 | -42.57 | -41.19 | -46.96 | -41.06 | -32.51 | -25.01 | -19.53 | -24.26 | -21.48 | -22.29 | -24.27 | -36.51 | -48.37 | -58.83 | -64.99 | -51.55 | -43.85 | -46.99 | -39.29 | -49.25 | -50.64 | -47.17 | -43.00 | -103.99 | -156.08 | -179.87 | -201.07 | -130.12 | -69.99 | -30.33 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-127.53 | -79.44 | -93.48 | -72.57 | -65.06 | -46.37 | -67.58 | -74.74 | -67.76 | -48.49 | -62.15 | -54.60 | -63.89 | -52.42 | -71.55 | -64.07 | -53.83 | -43.58 | -33.54 | -37.56 | -32.80 | -27.92 | -37.69 | -50.77 | -65.40 | -80.13 | -81.67 | -65.47 | -53.54 | -53.90 | -41.57 | -50.54 | -52.42 | -44.59 | -30.40 | -22.32 | -5.28 | 11.73 | 17.79 | 17.79 | 9.71 | 4.20 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 18.6 | 19.3 | 7.5 | 7.6 | 8.3 | 7.6 | 7.6 | 0.6 | 0.6 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency